GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » Median PS Value

Access Bio (XKRX:950130) Median PS Value : ₩11,411.45 (As of May. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Access Bio Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Access Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩3997.846. Access Bio's 10-Year median PS Ratio is 2.8544. Therefore, the Median PS Value for today is ₩11,411.45.

As of today (2024-05-27), Access Bio's share price is ₩6880.00. Access Bio's Median PS Value is ₩11,411.45. Therefore, Access Bio's Price to Median PS Value for today is 0.60.

The historical rank and industry rank for Access Bio's Median PS Value or its related term are showing as below:

XKRX:950130' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14   Med: 0.29   Max: 0.65
Current: 0.6

During the past 12 years, the highest Price to Median PS Value of Access Bio was 0.65. The lowest was 0.14. And the median was 0.29.

XKRX:950130's Price-to-Median-PS-Value is ranked better than
65.85% of 82 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.81 vs XKRX:950130: 0.60

Access Bio Median PS Value Historical Data

The historical data trend for Access Bio's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio Median PS Value Chart

Access Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 85,094.60 27,525.30

Access Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36,963.40 31,727.60 29,502.70 27,525.30 11,411.50

Competitive Comparison of Access Bio's Median PS Value

For the Diagnostics & Research subindustry, Access Bio's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Access Bio's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Access Bio's Price-to-Median-PS-Value falls into.



Access Bio Median PS Value Calculation

Access Bio's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=3997.846*2.8544
=11,411.45

10-Year Median PS Ratio is 2.8544.
Access Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3997.846.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Access Bio  (XKRX:950130) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Access Bio's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=6880.00/11,411.45
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Access Bio Median PS Value Related Terms

Thank you for viewing the detailed overview of Access Bio's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Access Bio (XKRX:950130) Business Description

Traded in Other Exchanges
N/A
Address
65 Clyde Road, Suite A, Somerset, NJ, USA, 08873
Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines